Literature DB >> 22750672

HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection.

Karin Neukam1, Silvia García-Rey, Celia Cifuentes, Juan Macías, José A Mira, María J Vázquez, Manuel Parra-Sánchez, José C Palomares, Nicolás Merchante, Federico A Di Lello, Juan A Pineda.   

Abstract

The influence of HIV coinfection on plasma hepatitis C virus (HCV) RNA load has not been reliably evaluated. We analyzed plasma HCV RNA load in 396 HCV-monoinfected and 467 HIV/HCV-coinfected patients. Median HCV RNA concentrations (interquartile range) in HCV-monoinfected patients were 5.88 (5.3-6.2) log(10)IU/mL versus 5.96 (5.6-6.5) log(10)IU/mL in HIV/HCV-coinfected individuals (p=0.033) as determined with the Cobas Amplicor Test and 6.06 (5.4-5.7) log(10)IU/mL versus 6.3 (5.5-6.9) log(10)IU/mL (p=0.026) using the Cobas TaqMan System. The plasma HCV RNA load in patients with HIV infection and undetectable plasmatic HIV RNA was similar to that observed in HCV-monoinfected individuals [6.02 (5.45-6.61) log(10)IU/mL versus 6.01 (5.36-6.59) log(10)IU/mL, respectively (p=1.0)]. In conclusion, HIV coinfection tends to be associated with higher plasma HCV RNA load, however, the magnitude of the differences is small and this effect can be counterbalanced with antiviral therapy.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750672     DOI: 10.1016/j.antiviral.2012.06.009

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.

Authors:  Daryoush Behzadpour; Abbas Ahmadi Vasmehjani; Seyed Dawood Mousavi Nasab; Nayeb Ali Ahmadi; Rasoul Baharlou
Journal:  Pathog Glob Health       Date:  2016-11-10       Impact factor: 2.894

2.  Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin.

Authors:  P Monje-Agudo; A Castro-Iglesias; A Rivero-Juárez; F Martínez-Marcos; E Ortega-González; L M Real; B Pernas; N Merchante; P Cid; J Macías; M D Merino; A Rivero; A Mena; K Neukam; J A Pineda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-09       Impact factor: 3.267

Review 3.  Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation.

Authors:  Stephen E Congly; Karen E Doucette; Carla S Coffin
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

4.  No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014.

Authors:  Karin Neukam; Pompeyo Viciana; Guillermo Ojeda-Burgos; Marcial Delgado-Fernández; María J Ríos; Juan Macías; Dolores Merino; Antonio Collado; Francisco Téllez; Juan A Pineda
Journal:  BMC Infect Dis       Date:  2016-09-15       Impact factor: 3.090

5.  [Hepatitis C: New diagnosis and seroconversions in a Madrid sexually transmitted diseases clinic].

Authors:  E E Lozano Rincón; C Rodríguez Martín; O Ayerdi Aguirrebengoa; M Vera García; R Serrano Heranz; J Del Romero Guerrero
Journal:  Rev Esp Quimioter       Date:  2019-09-26       Impact factor: 1.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.